Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications.
Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis.
Neurological diseases in pregnancy.
Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial.
Impact of a 10-week individualized exercise program on physical function and fatigue of people with multiple sclerosis: a pilot study.
Th17 and Non-Classic Th1 Cells in Chronic Inflammatory Disorders: Two Sides of the Same Coin.
Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
IL-23 Plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects.
Neurogenic pulmonary edema in pediatric multiple sclerosis: patient report and summary of cases.
The Effect of Community Exercise Interventions for People with MS Who Use Bilateral Support for Gait.
The Olig family affects central nervous system development and disease.
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis.
[Multiple sclerosis and pregnancy].
Patients with neuromuscular disorder.
Guidelines on PML risk stratification and diagnosis in patients with MS treated with natalizumab: so far so good?
Interlukin-18 Is a Pivot Regulatory Factor on Matrix Metalloproteinase-13 Expression and Brain Astrocytic Migration.
Current management of relapsing-remitting multiple sclerosis.
Heparin-induced thrombocytopenia following plasma exchange in patients with demyelinating neurological disease.
The risk of cancer from azathioprine as a treatment for multiple sclerosis.
Multiple sclerosis following anti-tumor necrosis factor-alpha therapy for psoriasis: first case in Italy? Case report and review of the literature.
Autonomic Dysregulation in Multiple Sclerosis.
Seroconversion of neuromyelitis optica spectrum disorder with hyperCKemia: a case report.
Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients.
Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?
[Therapeutic options for autoimmune encephalomyelitis].
Pages
« first
‹ previous
…
466
467
468
469
470
471
472
473
474
…
next ›
last »